Avenir Corp - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 209 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.

Quarter-by-quarter ownership
Avenir Corp ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$166,579
-18.8%
30,5650.0%0.02%
-11.1%
Q2 2023$205,091
-24.2%
30,565
-0.3%
0.02%
-30.8%
Q1 2023$270,640
+15.6%
30,6500.0%0.03%
+13.0%
Q4 2022$234,166
+7.4%
30,6500.0%0.02%0.0%
Q3 2022$218,000
-50.2%
30,650
-43.3%
0.02%
-45.2%
Q2 2022$438,000
+8.7%
54,100
+86.6%
0.04%
+31.2%
Q1 2022$403,000
-48.7%
29,000
+3.6%
0.03%
-47.5%
Q4 2021$786,000
-17.4%
28,0000.0%0.06%
-23.8%
Q3 2021$952,000
-16.8%
28,0000.0%0.08%
-12.1%
Q2 2021$1,144,000
+1.5%
28,0000.0%0.09%
-6.2%
Q1 2021$1,127,000
-31.9%
28,0000.0%0.10%
-38.6%
Q4 2020$1,656,000
+21.6%
28,0000.0%0.16%
+11.3%
Q3 2020$1,362,000
+0.5%
28,0000.0%0.14%
-7.8%
Q2 2020$1,355,00028,0000.15%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q3 2020
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 2,377,665$12,958,27412.23%
Eagle Health Investments LP 1,214,860$6,620,9871.46%
Matrix Capital Management Company, LP 11,572,590$63,070,6160.76%
Aristotle Atlantic Partners, LLC 3,058,206$16,667,2230.67%
VIKING GLOBAL INVESTORS LP 29,993,708$163,465,7090.66%
Pier Capital, LLC 719,067$3,918,9150.63%
DDD Partners, LLC 783,697$3,385,5710.49%
ARK Investment Management 11,509,308$62,725,7280.48%
Nikko Asset Management Americas, Inc. 6,570,939$35,680,1990.43%
Triatomic Management LP 102,889$560,7450.39%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders